DOES EFFECTIVE COMMUNICATION OF DIETARY RECOMMENDATIONS ALONG WITH PRESCRIBED LAXATIVE IN CHILDREN WITH FUNCTIONAL CONSTIPATION, HAVE ADDED THERAPEUTIC BENEFIT

Authors

  • Viratveer Yadav
  • Veenu Agarwal
  • Rakesh Shetty
  • K C Aggarwal
  • Vishwani Arora

DOI:

https://doi.org/10.47750/pnr.2022.13.S06.031

Keywords:

Functional constipation, Diet, Fibre, fluid intake, behaviour modification, children

Abstract

Introduction: The present study was aimed to know whether the effective communication of dietary recommendations would have added therapeutic benefit in children with functional constipation on laxatives.
Material and methods: A total of 106 children of functional constipation, age 1 to18 years who attended general Pediatrics OPD were enrolled. Consecutively enrolled children with odd number were placed in group 1 & rest were placed in group 0. All were advised to take laxative polyethylene glycol (PEG) for 6- 12 months, maintain stool diary & to come for follow up at 10 to15 days,1, 3 & 6 months. Group 0 was attended in usual way in OPD while group 1 was explained the desired changes in diet & toilet schedule in structured format & written handouts were given. Primary outcome was number of stools per week & stool form on BSFS assessed beyond 3 months.
Results: Group 1 and 0 were almost same in initial months in terms of cure rates but beyond 3 months the kids in former group were better in terms of softer stools, higher number of stools per week & also subjective improvement reported by many (71 % in group 1 vs 52% in group 0) and fewer relapses (17.8% in former vs 38.9% in later).
Conclusion: The effective communication of changes in diet and toilet habits are helpful mainly in long term follow up, associated with higher objective improvement rates &fewer relapses.

Downloads

Published

2022-10-06

Issue

Section

Articles

How to Cite

DOES EFFECTIVE COMMUNICATION OF DIETARY RECOMMENDATIONS ALONG WITH PRESCRIBED LAXATIVE IN CHILDREN WITH FUNCTIONAL CONSTIPATION, HAVE ADDED THERAPEUTIC BENEFIT. (2022). Journal of Pharmaceutical Negative Results, 209-214. https://doi.org/10.47750/pnr.2022.13.S06.031